In a sense, every investor is a growth investor. Even those who are primarily seeking income enjoy when the stocks they buy ...

Ozempic and Wegovy, the widely popular forms of semaglutide sold to treat diabetes and obesity, have officially been removed ...

Compounding pharmacies producing cheaper semaglutide products have been given notice they will soon have to stop, as the drug ...

The DOJ backs Medicare price negotiations amidst a Novartis lawsuit, while President Trump vows to lower U.S. drug costs.

We recently published a list of 12 Best Global Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where AstraZeneca PLC (NASDAQ:AZN) stands against other best ...

AstraZeneca AZN stock has risen 8.6% in the past month, mainly due to mixed fourth-quarter results and a positive update from ...

Ionis relies on upfront payments and licensing fees from partners, as well as Spinraza royalties, to drive revenue today, but its rapidly advancing portfolio should help diversify revenue. 2025 is ...

Merck’s Keytruda may be the most talked about drug facing loss of exclusivity but it’s far from the only one, as several of ...

Where could be the top place to invest this spring? Europe. That's according to the latest edition of the hugely influential ...

An index of Indian pharmaceutical company shares slid 2% to its lowest level in seven months on Wednesday after U.S.

Pascal Soriot (pictured) topped up his basic salary of £1.8m with extras that included a bonus of £3.5m and share awards ...

Commenting on this year’s 2025 Best Workplaces in UAE™ list Mohammed AlShair, Executive Chairman of Great Place to Work® ...